228 related articles for article (PubMed ID: 2092)
1. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
Keyriläinen O; Uustialo A
Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoprolol in angina pectoris. A subacute study with exercise tests and a long-term tolerability study.
Keyriläinen O; Uusitalo A
Acta Med Scand; 1976; 199(6):491-7. PubMed ID: 7100
[TBL] [Abstract][Full Text] [Related]
3. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
Uusitalo AJ; Keyriläinen O
Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of three beta 1-adrenoreceptor blocking drugs with different degree of intrinsic stimulating activity (metoprolol, practolol and H 87/07) in patients with angina pectoris.
Keyriläinen O; Uusitalo A
Ann Clin Res; 1978 Aug; 10(4):185-90. PubMed ID: 30388
[TBL] [Abstract][Full Text] [Related]
5. Effects of the cardioselective beta-adrenergic receptor blocking agent metoprolol in angina pectoris. Subacute study with exercise tests.
Ekelund LG; Olsson AG; Orö L; Rössner S
Br Heart J; 1976 Feb; 38(2):155-61. PubMed ID: 4080
[TBL] [Abstract][Full Text] [Related]
6. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
Frick MH; Luurila O
Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
[TBL] [Abstract][Full Text] [Related]
7. Effects of a new beta1-selective beta-blocker H 87/07 in angina pectoris.
Hedbäck B; Nordenfelt I; Svanström B; Vedin A; Wilhelmsson C; Oberg K
Ann Clin Res; 1977 Oct; 9(5):305-10. PubMed ID: 28687
[TBL] [Abstract][Full Text] [Related]
8. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
Rousseau MF; Pouleur H; Cocco G; Wolff AA
Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
Klein W; Fluch N; Brandt D
Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
[TBL] [Abstract][Full Text] [Related]
10. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
[TBL] [Abstract][Full Text] [Related]
11. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
Jonker JJ; de Klerk J; den Ottolander GJ
Arzneimittelforschung; 1981; 31(7):1140-2. PubMed ID: 6115654
[TBL] [Abstract][Full Text] [Related]
12. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
[TBL] [Abstract][Full Text] [Related]
13. [Effect of metoprolol on the exercise tolerance in patients with stable angina pectoris (author's transl)].
Tomei G; Mosti G; Veltri M; Giusti C
G Ital Cardiol; 1978; 8(12):1286-92. PubMed ID: 367865
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Szwed H; Sadowski Z; Elikowski W; Koronkiewicz A; Mamcarz A; Orszulak W; Skibińska E; Szymczak K; Swiatek J; Winter M
Eur Heart J; 2001 Dec; 22(24):2267-74. PubMed ID: 11728147
[TBL] [Abstract][Full Text] [Related]
15. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
[TBL] [Abstract][Full Text] [Related]
16. Cardioselective beta-blockade with metoprolol in rest angina: a randomized, double-blind, placebo-controlled, cross-over trial.
Polese A; De Cesare N; Loaldi A; Lundgren B; Savonitto S
Cardiologia; 1989 Apr; 34(4):333-9. PubMed ID: 2667758
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
N Engl J Med; 1979 Apr; 300(14):750-5. PubMed ID: 581782
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of results from exercise testing in patients with chronic stable angina pectoris treated with metoprolol or verapamil. A report from the Angina Prognosis Study In Stockholm (APSIS).
Forslund L; Hjemdahl P; Held C; Björkander I; Eriksson SV; Brodin U; Rehnqvist N
Eur Heart J; 2000 Jun; 21(11):901-10. PubMed ID: 10806014
[TBL] [Abstract][Full Text] [Related]
19. [Metoprolol effect on ECG exercise test in patients with stable angina pectoris. Computer analysis (author's transl)].
Manca C; Bruno G; Burani F; Dei Cas L; Percoco G; Scarfò S
G Ital Cardiol; 1979; 9(10):1104-9. PubMed ID: 261957
[TBL] [Abstract][Full Text] [Related]
20. Improvement of left ventricular contractility and relaxation with the beta 1-adrenergic receptor partial agonist xamoterol at rest and during exercise in patients with postinfarction left ventricular dysfunction. A placebo-controlled randomized trial.
de Feyter PJ; Serruys PW; Suryapranata H
Circulation; 1990 Feb; 81(2 Suppl):III99-106. PubMed ID: 1967562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
